Clinical Indication ID & Name
NIPD for cystic fibrosis - haplotype testing
Test Group
NIPD
Specialties
Test code
R304.1
Test name
N/A
Target genes
CFTR
Test scope
n/a
Test method/ technology
NIPD
Optimal Family Structure
n/a
Eligibility Criteria
1. Pregnancy at risk of cystic fibrosis for which NIPD by haplotype testing is required following discussion with testing laboratory, where parents are not consanguineous AND
2. Each partner carries a confirmed mutation and DNA is available from both parents, AND
3. DNA is available from either an affected child/pregnancy OR a confirmed unaffected non-carrier child/pregnancy
Testing is not currently possible for consanguineous couples
Testing may not be possible in multiple pregnancies. In such cases contact the laboratory for discussion
Commissioning group
Specialised
Overlapping idications
n/a
Address for samples/request forms
North Thames GLH, Rare & Inherited Disease Genomic Laboratory
Specimen Reception, Level 5 Barclay House, 37 Queen Square,
London WC1N 3BH
Contact with queries
Supporting documents
Rare Disese WGS Clinician pack
Education resources
n/a
Service updates
n/a
Consent record
See consent guidance in test request form
Sample requirements
See sample guidance in test request form